MedTrace Logo

Influence of Preoperative Immunomodulation by Oral Impact on Postoperative Complications Following Cystectomies & Nephrectomies

NCT05520151 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 214

Last updated 2024-07-15

No results posted yet for this study

Summary

any studies have shown the benefit of perioperative Oral Impact immunomodulation in gastrointestinal, ENT, gynecological and cardiac surgery. Studies in major Urological surgery are rare and not very contributory. The expected benefit is a reduction in postoperative complications and the average length of stay.

Conditions

  • Urological Manifestations

Interventions

DIETARY_SUPPLEMENT

ORAL IMPACT treatment

the group of patients will be received a 7-days course of ORAL IMPACT

OTHER

control

no intervention

Sponsors & Collaborators

  • Centre Hospitalier Intercommunal Robert Ballanger

    lead OTHER

Principal Investigators

  • Serge NDOKO, MD · Robert ballanger

  • MAtthieu CAMBY, MD · Centre Hospitalier Intercommunal André Grégoire

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-30
Primary Completion
2025-01-31
Completion
2025-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05520151 on ClinicalTrials.gov